Ann: Zelda to merge with US-based Ilera Therapeutics, page-252

Gday Cue. I have been lucky enough to have owned a couple of Biomeds that have hit paydirt.

A product that works is great for the share price. But the big share price rise didnt happen until the company was bought out by Big pharma, or the product was licenced to be sold by big pharma.

Its the sales and revenue potential that makes a share price really fly.

Long term, I think we are onto a good thing with this melding of companies. Size and momentum matter just as much as the product, and it looks like the products are going to be great

I can see why short term holders waiting for a trial announcement and the pump to dump are miffed though. For them this will cost them money.

C'est la vie